Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AT44
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016787 | hydrolase activity | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.395 |
CLV_NRD_NRD_1 | 312 | 314 | PF00675 | 0.545 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.342 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 289 | 291 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.361 |
CLV_PCSK_SKI1_1 | 289 | 293 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 317 | 321 | PF00082 | 0.565 |
CLV_Separin_Metazoa | 310 | 314 | PF03568 | 0.465 |
DOC_CDC14_PxL_1 | 12 | 20 | PF14671 | 0.436 |
DOC_CDC14_PxL_1 | 333 | 341 | PF14671 | 0.433 |
DOC_CYCLIN_yCln2_LP_2 | 169 | 175 | PF00134 | 0.382 |
DOC_CYCLIN_yCln2_LP_2 | 356 | 359 | PF00134 | 0.371 |
DOC_CYCLIN_yCln2_LP_2 | 67 | 73 | PF00134 | 0.445 |
DOC_MAPK_MEF2A_6 | 167 | 176 | PF00069 | 0.378 |
DOC_MAPK_MEF2A_6 | 81 | 90 | PF00069 | 0.401 |
DOC_PP2B_LxvP_1 | 169 | 172 | PF13499 | 0.338 |
DOC_PP2B_LxvP_1 | 306 | 309 | PF13499 | 0.463 |
DOC_PP2B_LxvP_1 | 356 | 359 | PF13499 | 0.356 |
DOC_PP4_FxxP_1 | 59 | 62 | PF00568 | 0.503 |
DOC_USP7_MATH_1 | 229 | 233 | PF00917 | 0.504 |
DOC_USP7_MATH_1 | 270 | 274 | PF00917 | 0.530 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.720 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.678 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.591 |
DOC_USP7_UBL2_3 | 211 | 215 | PF12436 | 0.507 |
DOC_WW_Pin1_4 | 190 | 195 | PF00397 | 0.327 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.426 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.463 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.440 |
DOC_WW_Pin1_4 | 261 | 266 | PF00397 | 0.290 |
DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.606 |
LIG_14-3-3_CanoR_1 | 269 | 275 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 313 | 317 | PF00244 | 0.507 |
LIG_Actin_WH2_2 | 71 | 89 | PF00022 | 0.416 |
LIG_BRCT_BRCA1_1 | 132 | 136 | PF00533 | 0.334 |
LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.512 |
LIG_EH1_1 | 143 | 151 | PF00400 | 0.388 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.433 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.562 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.451 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.538 |
LIG_LIR_Apic_2 | 56 | 62 | PF02991 | 0.505 |
LIG_LIR_LC3C_4 | 257 | 261 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 10 | 15 | PF02991 | 0.329 |
LIG_PDZ_Class_2 | 361 | 366 | PF00595 | 0.381 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.378 |
LIG_SH2_CRK | 12 | 16 | PF00017 | 0.414 |
LIG_SH2_CRK | 191 | 195 | PF00017 | 0.388 |
LIG_SH2_NCK_1 | 73 | 77 | PF00017 | 0.429 |
LIG_SH2_SRC | 73 | 76 | PF00017 | 0.387 |
LIG_SH2_STAP1 | 282 | 286 | PF00017 | 0.424 |
LIG_SH2_STAT3 | 282 | 285 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 175 | 178 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.362 |
LIG_SH3_1 | 236 | 242 | PF00018 | 0.390 |
LIG_SH3_2 | 239 | 244 | PF14604 | 0.367 |
LIG_SH3_2 | 50 | 55 | PF14604 | 0.602 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.466 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.473 |
LIG_SH3_3 | 249 | 255 | PF00018 | 0.336 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.457 |
LIG_SH3_3 | 334 | 340 | PF00018 | 0.475 |
LIG_SH3_3 | 352 | 358 | PF00018 | 0.332 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.662 |
LIG_SUMO_SIM_anti_2 | 257 | 262 | PF11976 | 0.398 |
LIG_SUMO_SIM_par_1 | 360 | 365 | PF11976 | 0.317 |
LIG_SUMO_SIM_par_1 | 87 | 94 | PF11976 | 0.364 |
LIG_TRAF2_1 | 222 | 225 | PF00917 | 0.340 |
LIG_TRAF2_1 | 273 | 276 | PF00917 | 0.492 |
LIG_WRPW_2 | 214 | 217 | PF00400 | 0.442 |
MOD_CDK_SPK_2 | 190 | 195 | PF00069 | 0.386 |
MOD_CDK_SPxxK_3 | 48 | 55 | PF00069 | 0.562 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.365 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.423 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.615 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.478 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.260 |
MOD_CK2_1 | 270 | 276 | PF00069 | 0.537 |
MOD_Cter_Amidation | 209 | 212 | PF01082 | 0.384 |
MOD_GlcNHglycan | 131 | 135 | PF01048 | 0.343 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.458 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.689 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.616 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.344 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.403 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.612 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.615 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.434 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.604 |
MOD_PIKK_1 | 280 | 286 | PF00454 | 0.336 |
MOD_PK_1 | 99 | 105 | PF00069 | 0.399 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.533 |
MOD_PKA_2 | 312 | 318 | PF00069 | 0.498 |
MOD_PKB_1 | 97 | 105 | PF00069 | 0.393 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.365 |
MOD_Plk_1 | 137 | 143 | PF00069 | 0.394 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.359 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.399 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.364 |
MOD_Plk_4 | 357 | 363 | PF00069 | 0.428 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.609 |
MOD_ProDKin_1 | 190 | 196 | PF00069 | 0.328 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.423 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.459 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.434 |
MOD_ProDKin_1 | 261 | 267 | PF00069 | 0.300 |
MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.606 |
TRG_DiLeu_BaEn_2 | 116 | 122 | PF01217 | 0.473 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.341 |
TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 243 | 246 | PF00400 | 0.444 |
TRG_ER_diArg_1 | 288 | 290 | PF00400 | 0.397 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3I7 | Leptomonas seymouri | 58% | 100% |
A0A0S4J6J0 | Bodo saltans | 29% | 100% |
A0A3Q8IW24 | Leishmania donovani | 93% | 100% |
A4HPD3 | Leishmania braziliensis | 81% | 100% |
A4ICH3 | Leishmania infantum | 93% | 100% |
O15442 | Homo sapiens | 24% | 100% |
Q4Q1F4 | Leishmania major | 89% | 100% |
Q91ZG2 | Mus musculus | 24% | 100% |